The Nasdaq Biotechnology Index rose by 1.29%. Among the constituent stocks, CG Oncology increased by 24.99%, UroGen Pharma rose by 14.08%, and ADMA Biologics climbed by 12.03%. In contrast, Neurogene fell by 5.91%, Amylyx Pharmaceuticals dropped by 6.53%, and Q32 Bio decreased by 9.89%Wallstreetcn·Apr 28, 2025 at 08:42 PMCGON-3.85%ADMA+0.44%
